Obligacje
Poniżej znajduje się lista obligacji korporacyjnych Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| 5,65% | 44 K | 88,40% | 4,650% | 2044-06-15 | 38,34 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,53% | 0 | 56,37% | 1,625% | 2043-09-14 | 250 M GBP | 1 000,00 GBP | 100 000,00 GBP | Eli Lilly & Co. | |
| 5,46% | 23,36 M | 102,96% | 5,650% | 2065-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,45% | 6,14 M | 102,32% | 5,600% | 2065-02-12 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,45% | 9,93 M | 94,33% | 5,100% | 2064-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,45% | 7,09 M | 95,97% | 5,200% | 2064-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,43% | 752 K | 92,31% | 4,950% | 2063-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,39% | 0 | 80,86% | 4,150% | 2059-03-15 | 591,29 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,36% | 20,76 M | 102,75% | 5,550% | 2055-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,35% | 44,86 M | 102,12% | 5,500% | 2055-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,34% | 1,05 M | 95,03% | 5,000% | 2054-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,34% | 0 | 58,01% | 2,250% | 2050-05-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,34% | 8,76 M | 93,34% | 4,875% | 2053-02-27 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,33% | 9,19 M | 95,80% | 5,050% | 2054-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,33% | 0 | 81,64% | 3,950% | 2049-03-15 | 958,15 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,28% | 0 | 86,61% | 3,875% | 2039-03-15 | 240,25 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,24% | 0 | 56,30% | 2,500% | 2060-09-15 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,22% | 1,07 M | 83,63% | 3,950% | 2047-05-15 | 346,95 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,19% | 200 K | 81,93% | 3,700% | 2045-03-01 | 386,8 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,01% | 4 K | 113,94% | 6,770% | 2036-01-01 | 158,56 M USD | 1 000,00 USD | 1 000,00 USD | Eli Lilly & Co. | |
| 4,91% | 8,37 M | 100,01% | 5,000% | 2026-02-27 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,75% | 8 K | 110,89% | 5,950% | 2037-11-15 | 266,83 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,69% | 50,4 M | 101,59% | 4,900% | 2035-10-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,61% | 12,26 M | 103,67% | 5,100% | 2035-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,58% | 3,49 M | 108,51% | 5,550% | 2037-03-15 | 444,73 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,55% | 7,78 M | 100,36% | 4,600% | 2034-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,54% | 4,04 M | 101,06% | 4,700% | 2034-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,36% | 4,43 M | 102,09% | 4,700% | 2033-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,35% | 4,78 M | 101,18% | 4,550% | 2032-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,27% | 1,78 M | 103,39% | 4,900% | 2032-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,20% | 19,86 M | 100,21% | 4,250% | 2031-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,13% | 0 | 48,86% | 1,375% | 2061-09-14 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,03% | 1,41 M | 102,78% | 4,750% | 2030-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,97% | 0 | 98,14% | 3,375% | 2029-03-15 | 930,56 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,95% | 1,21 M | 101,68% | 4,500% | 2029-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,91% | 0 | 55,20% | 1,125% | 2051-09-14 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 3,89% | 172 K | 101,08% | 4,200% | 2029-08-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,88% | 23,81 M | 100,31% | 4,000% | 2028-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,86% | 0 | 66,60% | 1,700% | 2049-11-01 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 3,82% | 111 K | 101,56% | 4,550% | 2028-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,82% | 2,51 M | 100,84% | 4,500% | 2027-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,79% | 5,52 M | 100,63% | 4,150% | 2027-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,77% | 1,43 M | 102,30% | 5,500% | 2027-03-15 | 364,32 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,72% | 15 K | 99,10% | 3,100% | 2027-05-15 | 401,45 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 2,91% | 0 | 83,25% | 0,500% | 2033-09-14 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,75% | 0 | 88,37% | 0,625% | 2031-11-01 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,61% | 0 | 97,92% | 2,125% | 2030-06-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,16% | 0 | 99,69% | 1,625% | 2026-06-02 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 0,49% | 0 | 99,89% | 0,450% | 2028-05-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Eli Lilly & Co. | |
| — | 5,3 M | 100,36% | 4,816% | 2028-10-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |